Daniel Dreidax
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Super enhancers define regulatory subtypes and cell identity in neuroblastoma.
Journal: Nature cancer
Published: September 11, 2019
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma.
Journal: Life science alliance
Published: February 04, 2019
Minichromosome Maintenance Complex Is a Critical Node in the miR-183 Signaling Network of MYCN-Amplified Neuroblastoma Cells.
Journal: Journal of proteome research
Published: May 31, 2016
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients.
Journal: Science signaling
Published: December 24, 2015
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas.
Journal: Cancer research
Published: September 11, 2015
Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Journal: Nature
Published: April 17, 2015
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Journal: Human molecular genetics
Published: August 09, 2014
CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.
Journal: Cell cycle (Georgetown, Tex.)
Published: March 07, 2013
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
Journal: Human molecular genetics
Published: January 25, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026